Fox Chase to host Cancer Epigenetics Institute Symposium

Van Andel scientists develop improved single-cell DNA methylation technique

Van Andel Institute scientists have developed an improved technique to comprehensively profile DNA methylation in single cells, an advance that will help researchers better study the role of epigenetics in cancer and other diseases.

July 25, 2025

Vol.51 No.29

Clinical Roundup

Epigenetic research reveals a potential treatment for CRC and other solid tumors

A little-known mouse protein disrupts cancer-causing chemical changes to genes associated with human colorectal cancer cells and potentially could be used to treat solid tumors, according to a new study from researchers at the Johns Hopkins Kimmel Cancer Center and the Chinese Academy of Sciences.

January 17, 2025

Vol.51 No.02

Tumors are able to form with no DNA mutations, fly study shows

Tumors are able to form without any DNA mutations, according to a recent proof-of-principle study performed in flies. Epigenetic changes alone—even temporary alterations—induced permanent cancer cell fate.

Upregulating TERT gene expression reverses multiple hallmarks of aging

Researchers at MD Anderson Cancer Center have demonstrated that therapeutically restoring ‘youthful’ levels of a specific subunit of the telomerase enzyme can significantly reduce the signs and symptoms of aging in preclinical models.

June 28, 2024

Vol.50 No.26

Clinical Roundup

T-cell aging not limited by organismal age, allowing healthy cells to proliferate in perpetuity

While most cell types experience a functional decline after years of proliferation and replication, T cells can proliferate seemingly indefinitely and without detriment.

June 14, 2024

Vol.50 No.24

Clinical Roundup

Epigenomic platform may predict NSCLC immunotherapy response using liquid biopsies

Data published in The Journal for ImmunoTherapy of Cancer show ClearNote Health’s epigenomic platform may provide a novel tissue-free, liquid biopsy-based approach for prediction and monitoring of immunotherapy response for non-small cell lung cancer patients.

January 19, 2024

Vol.50 No.03

Fox Chase to host Cancer Epigenetics Institute Symposium

YOU MAY BE INTERESTED IN

Van Andel scientists develop improved single-cell DNA methylation technique

Epigenetic research reveals a potential treatment for CRC and other solid tumors

Tumors are able to form with no DNA mutations, fly study shows

Upregulating TERT gene expression reverses multiple hallmarks of aging

T-cell aging not limited by organismal age, allowing healthy cells to proliferate in perpetuity

Epigenomic platform may predict NSCLC immunotherapy response using liquid biopsies

Renew today!

Subscriber content

Never miss an issue!

Login